Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents

[41] Zhang J(2014)The role of dietary histone deacetylases (HDACs) inhibitors in health and disease Nutrients 6 4273-2616

[42] Yao J(2016)Natural compound histone deacetylase inhibitors (HDACi): Synergy with inflammatory signaling pathway modulators and clinical applications in cancer Molecules 21 1608-2605

[43] Liu Y(2004)A novel mechanism of chemoprotection by sulforaphane Cancer Research 64 5767-53365

[44] Fang J(1996)Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase Proceedings of the National Academy of Sciences 93 13143-492

[45] Yoon S(2017)Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities MedChemComm 8 1213-105

[46] Eom GH(2016)An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells Chemico-Biological Interactions 253 112-470

[47] Sanaei M(2014)Biological activities of novel pyrazolyl hydroxamic acid derivatives against human lung cancer cell line A549 European Journal of Medicinal Chemistry 83 516-228

[48] Kavoosi F(2007)Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors Bioorganic & Medicinal Chemistry Letters 17 4895-103

[49] Seo J-Y(2017)Histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induces apoptosis in prostate cancer cell lines via the Akt/FOXO3a signaling pathway Medical Science Monitor 23 5793-760

[50] Park Y-J(2014)Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels International Journal of Oncology 44 1745-29

[41] Zhang J(2014)The role of dietary histone deacetylases (HDACs) inhibitors in health and disease Nutrients 6 4273-2616

[42] Yao J(2016)Natural compound histone deacetylase inhibitors (HDACi): Synergy with inflammatory signaling pathway modulators and clinical applications in cancer Molecules 21 1608-2605

[43] Liu Y(2004)A novel mechanism of chemoprotection by sulforaphane Cancer Research 64 5767-53365

[44] Fang J(1996)Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase Proceedings of the National Academy of Sciences 93 13143-492

[45] Yoon S(2017)Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities MedChemComm 8 1213-105

[46] Eom GH(2016)An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells Chemico-Biological Interactions 253 112-470

[47] Sanaei M(2014)Biological activities of novel pyrazolyl hydroxamic acid derivatives against human lung cancer cell line A549 European Journal of Medicinal Chemistry 83 516-228

[48] Kavoosi F(2007)Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors Bioorganic & Medicinal Chemistry Letters 17 4895-103

[49] Seo J-Y(2017)Histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), induces apoptosis in prostate cancer cell lines via the Akt/FOXO3a signaling pathway Medical Science Monitor 23 5793-760

[50] Park Y-J(2014)Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels International Journal of Oncology 44 1745-29